Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Abdallah Damin Abukhalil, Tala Al Sheikh, Sandra Muallem, Ni’meh Al-Shami & Hani A Naseef. (2023) Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine. Patient Preference and Adherence 17, pages 749-759.
Read now
Read now
Siavosh Naji-Talakar, Sheena Sharma, Leslie A. Martin, Derek Barnhart & Bhagwat Prasad. (2021) Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units. Expert Opinion on Drug Metabolism & Toxicology 17:3, pages 273-289.
Read now
Read now
Chang Hoon Lee, Francesco Franchi & Dominick J. Angiolillo. (2020) Clopidogrel drug interactions: a review of the evidence and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1079-1096.
Read now
Read now
Zhi-Yu Wang, Meng Chen, Ling-Ling Zhu, Lu-Shan Yu, Su Zeng, Mei-Xiang Xiang & Quan Zhou. (2015) Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Therapeutics and Clinical Risk Management 11, pages 449-467.
Read now
Read now
Articles from other publishers (16)
Muzamil Khawaja, Janki Thakker, Riyad Kherallah, Masafumi Kitakaze, Hani Jneid, Dominick J. Angiolillo & Yochai Birnbaum. (2022) Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers. Cardiovascular Drugs and Therapy.
Crossref
Crossref
Siri Kalyan Chirumamilla, Venkatesh Teja Banala, Masoud Jamei & David B. Turner. (2021) Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents. Pharmaceutics 13:8, pages 1169.
Crossref
Crossref
Joon Sung KimByung-Wook Kim. (2019) A Review of the 2018 Asia-Pacific Working Group Consensus on Non-variceal Upper Gastrointestinal Bleeding. The Korean Journal of Gastroenterology 73:1, pages 16.
Crossref
Crossref
Joseph JY Sung, Philip WY Chiu, Francis K L Chan, James YW Lau, Khean-lee Goh, Lawrence HY Ho, Hwoon-young Jung, Jose D Sollano, Takuji Gotoda, Nageshwar Reddy, Rajvinder Singh, Kentaro Sugano, Kai-chun Wu, Chun-Yin Wu, David J Bjorkman, Dennis M Jensen, Ernst J Kuipers & Angel Lanas. (2018) Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut 67:10, pages 1757-1768.
Crossref
Crossref
Morten Würtz & Erik L. Grove. 2017. Thrombosis and Embolism: from Research to Clinical Practice. Thrombosis and Embolism: from Research to Clinical Practice
325
350
.
Charles E. LeonardWarren B. BilkerColleen M. BrensingerDavid A. FlockhartCristin P. FreemanScott E. KasnerStephen E. KimmelSean Hennessy. (2015) Comparative Risk of Ischemic Stroke Among Users of Clopidogrel Together With Individual Proton Pump Inhibitors. Stroke 46:3, pages 722-731.
Crossref
Crossref
J P Depta, P A Lenzini, D E Lanfear, T Y Wang, J A Spertus, R G Bach & S Cresci. (2014) Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction. The Pharmacogenomics Journal 15:1, pages 20-25.
Crossref
Crossref
Xi-Ling Jiang, Snehal Samant, Lawrence J. Lesko & Stephan Schmidt. (2015) Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel. Clinical Pharmacokinetics 54:2, pages 147-166.
Crossref
Crossref
Morten Würtz & Erik L. Grove. 2015.
R. Iwakiri, K. Higuchi, M. Kato, M. Fujishiro, Y. Kinoshita, T. Watanabe, T. Takeuchi, M. Yamauchi, M. Sanomura, H. Nakagawa, N. Sugisaki, Y. Okada, H. Ogawa, T. Arakawa & K. Fujimoto. (2014) Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low‐dose aspirin. Alimentary Pharmacology & Therapeutics 40:7, pages 780-795.
Crossref
Crossref
Asuman Celikbilek, Mehmet Celikbilek, Lutfi Akyol & Ilyas Pirti. (2013) Esomeprazole-induced irritability. Acta Neurologica Belgica 114:3, pages 251-252.
Crossref
Crossref
Tommy Andersson, Peter Nagy, Mohammad Niazi, Sven Nylander, Hal Galbraith, Santosh Ranjan & Lars Wallentin. (2014) Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers. American Journal of Cardiovascular Drugs 14:3, pages 217-227.
Crossref
Crossref
J. Szymezak & P. Gaussem. (2013) Inhibiteurs de la pompe à protons et clopidogrel (Plavix®) : une liaison dangereuse ?. La Revue de Médecine Interne 34:2, pages 99-104.
Crossref
Crossref
Jia Wu, Li-Tao Jia, Li-Ming Shao, Jia-Min Chen, Dan-Dan Zhong, Song Xu & Jian-Ting Cai. (2012) Drug–drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers. European Journal of Clinical Pharmacology 69:2, pages 179-187.
Crossref
Crossref
Tatyana Zvyaga, Shu-Ying Chang, Cliff Chen, Zheng Yang, Ragini Vuppugalla, Jeremy Hurley, Denise Thorndike, Andrew Wagner, Anjaneya Chimalakonda & A. David Rodrigues. (2012) Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19. Drug Metabolism and Disposition 40:9, pages 1698-1711.
Crossref
Crossref
Chia‐Hao Chen, Jyh‐Chin Yang, Yow‐Shieng Uang & Chun‐Jung Lin. (2012) Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel. Biopharmaceutics & Drug Disposition 33:5, pages 278-283.
Crossref
Crossref